首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素联合尿激酶治疗频发短暂性脑缺血
引用本文:汪志云,刘国萍,叶文翔. 低分子肝素联合尿激酶治疗频发短暂性脑缺血[J]. 中国慢性病预防与控制, 2005, 13(3): 121-122
作者姓名:汪志云  刘国萍  叶文翔
作者单位:天津市第一中心医院,神经内科,天津,300192
摘    要:目的探讨低分子肝素联合尿激酶治疗频发短暂性脑缺血(TIA)发作的疗效和安全性。方法将63例频发TIA患者分为治疗组和对照组。治疗组应用低分子肝素联合尿激酶,对照组仅用扩容治疗。观察两组治疗的总有效率及实验室指标(血小板计数、凝血酶原时间、部分凝血酶原时间和纤维蛋白原)。结果治疗组总有效率与对照组比较,差别有统计学意义,治疗前后实验室指标比较,差别无统计学意义。结论应用低分子肝素联合尿激酶治疗频发TIA是一种有效、安全的治疗方法。

关 键 词:低分子肝素  尿激酶  短暂性脑缺血
文章编号:1004-6194(2005)03-0121-02
修稿时间:2005-01-07

The Treatment of Recurrent TIA with the Combination of LMWH and Urokinase--A Clinical Study
WANG Zhi-yun,LIU Guo-ping,YE Wen-xiang. The Treatment of Recurrent TIA with the Combination of LMWH and Urokinase--A Clinical Study[J]. Chinese Journal of Prevention and Control of Chronic Non-Communicable Diseases, 2005, 13(3): 121-122
Authors:WANG Zhi-yun  LIU Guo-ping  YE Wen-xiang
Affiliation:WANG Zhi-yun,LIU Guo-ping and YE Wen-xiang. The Department of Intern Neurology,Tianjin The First Central Hospital,Tianjin 300192,China
Abstract:Objective To discuss the efficacy and security in the use of the combination of LMWH and urokinase in treating recurrent TIA. Method 63 cases of recurrent TIA were divided into 2 groups. In the treating group, LMWH combined with urokinase were given, while in the control group merely hypervolemic treatment was given. The total efficacy of the two groups, including the influences of platelet counts, prothrombin time, partial prothrombin time and fibrinogen had been observed before and after treatment. Results The total efficacy between the two groups was significantly different, but the laboratory items had no significant difference before and after treatment. Conclusion The use of LMWH combined with urokinase in treating recurrent TIA was an efficacious treatment with good security.
Keywords:LMWH  Urokinase  TIA
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号